Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases

Journal of Hepatology

Volumn 36, Issue 6, 2002, Pages 734-741

  Kunitani, Hitoshi ^a   Shimizu, Yukihiro ^a   Murata, Hiroyuki ^a   Higuchi, Kiyohiro ^a   Watanabe, Akiharu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Costimulatory molecules; Dendritic cells; Liver disease; Subset

Indexed keywords

ANTIGEN; CD123 ANTIGEN; CD4 ANTIGEN; CD83 ANTIGEN; GLYCOPROTEIN P 15095;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; VIRUS HEPATITIS;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIGENS, CD; ANTIGENS, CD11C; ANTIGENS, CD40; ANTIGENS, CD86; CHRONIC DISEASE; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LIVER; LIVER DISEASES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, INTERLEUKIN-3;

EID: 0036623462     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00062-4     Document Type: Article

References (21)

1. Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH. Immunology and the liver. Hepatology 1991;13:977-994.
2. + T cells associated with the control of infection. Gastroenterology 1999;117:1386-1396.
3. + T-cell expansion in patients with acute hepatitis C. Hepatology 2001;33:287-294.
4. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
5. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996;184:1953-1962.
6. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-1186.
7. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999;284:1835-1837.
8. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte response: intermediates, effctors, and memory cells. Science 2000;290:92-97.
9. Brivio F, Gilardi R, Bucocev R, Ferrante R, Rescaldani R, Vigore L, et al. Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression. Hepatogastroenterology 2000;47:1337-1339.
10. Bonfanti A, Lissoni P, Bucovec R, Rovelli F, Brivio F, Fumagalli L. Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer. Int J Biol Markers 2000;15:161-164.
11. Lissoni P, Vigore L, Ferranti R, Bukovec R, Meregalli S, Mandala M, et al. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. J Biol Regul Homeost Agents 1999;13:216-219.
12. Hata K, Zhang XR, Iwatsuki S, Van Thiel DH, Herberman RB, Whiteside TL. Isolation, phenotyping, and functional analysis of lymphocytes from human liver. Clin Immunol Immunopathol 1990;56:401-419.
13. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 1995;154:3821-3835.
14. + peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 1999;163:3250-3259.
15. Wan Y, Bramson J. Role of dendritic cell-derived cytokines in immune regulation. Curr Pharm Des 2001;7:977-992.
16. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, et al. The nature of the principal type 1 interferon- producing cells in human blood. Science 1999;284:1835-1837.
17. Jacob HS. Hypersplenism: mechanisms and management. Br J Haematol 1974;27:1-5.
18. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Mets DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000;174:47-62.
19. Yoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med 2001;193:35-49.
20. Tanimoto K, Akbar SM, Michitaka K, Horiike N, Onji M. Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis. Hepatol Res 2001;21:117-125.
21. Shimizu Y. Immunotherapy against unresectable or advanced liver cancer. Asian J Surg 2000;23:42-55.